Harriet de Wit
Directeur/Bestuurslid bij PHARMALA BIOTECH HOLDINGS INC.
Vermogen: 15 800 $ op 30-04-2024
Profiel
Harriet de Wit is currently a Director at Pharmala Biotech Holdings, Inc. and Pharmala Biotech, Inc. She is also a Professor at The University of Chicago.
She received her doctorate degree from Concordia University in 1981 and her undergraduate degree from the University of Calgary.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-02-2024 | 100 000 ( 0.12% ) | 15 800 $ | 30-04-2024 |
Actieve functies van Harriet de Wit
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Bestuurslid | 21-03-2021 |
| The University of Chicago | Corporate Officer/Principal | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Opleiding van Harriet de Wit
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |